Zoekresultaten - 12 results

Future of opioid markets in Europe: Foresight approaches

Abstract: Sources such as UNODC  report about the ban on opium production in Afghanistan in 2023. This ban might have an impact on the heroin market in Europe. It is difficult to foresee what the consequences ...

The use of nitrous oxide whippets as a recreational drug: Hidden health risks.

lead were found. STEM- EDX analysis confirmed the presence of nano-sized particles containing iron and zinc. When simulating inhalation, using the multiple path particle dosimetry model, it was confirmed ...

Full Characterisation of Heroin Samples Using Infrared Spectroscopy and Multivariate Calibration

Squares (PLS) modelling, in order to obtain qualitative and quantitative models based on real live samples. The approach showed that it was possible to identify and quantify heroin in the samples based on ...

Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)

before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and 2018 with a model ...

Prevalence of drug use before and during imprisonment in seven European countries (2014-2018)

This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. ...

Applying and implementing future-oriented methods on a national level; towards enhanced policy and service preparedness to threats in the drugs domain

foresight research can contribute to national drug information systems for better preparedness and how it can be developed and implemented at national levels. Methods A combination of more traditional ...

Reitox national reporting to EMCDDA on drugs and drug addiction, 2020

Yearly contribution to the European Monitor Center for Drugs and Drug Addiction (EMCDDA) in collecting, analysing and disseminating information on drugs and drug addiction in Europe. In order to fulfil its ...

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.

gabapentin has been licensed in the European Union only for neuropathic pain and epilepsy for patients who have partial seizures, it has also been prescribed in treatment for substance use disorders. Many ...

QR code

QR code for this page URL